Business Description
Syros Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US87184Q1076
Compare
Compare
Traded in other countries / regions
SYRS.USA0S90.Germany0LC7.UK IPO Date
2016-06-30Description
Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is mainly involved in the segments of pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.29 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.86 | |||||
| Debt-to-EBITDA | -0.72 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -5.1 | |||||
| Beneish M-Score | -2.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 33.7 | |||||
| 3-Year EBITDA Growth Rate | 27.3 | |||||
| 3-Year EPS without NRI Growth Rate | 26.4 | |||||
| 3-Year FCF Growth Rate | 18.4 | |||||
| 3-Year Book Growth Rate | -29.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | -8.83 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 7.29 | |||||
| 9-Day RSI | 14.3 | |||||
| 14-Day RSI | 22.42 | |||||
| 6-1 Month Momentum % | 45.32 | |||||
| 12-1 Month Momentum % | -39.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.38 | |||||
| Quick Ratio | 5.38 | |||||
| Cash Ratio | 5.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -67.2 | |||||
| Shareholder Yield % | 2.53 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1492.08 | |||||
| Net Margin % | -1065.37 | |||||
| ROE % | -101.59 | |||||
| ROA % | -45.63 | |||||
| ROIC % | -299.34 | |||||
| ROC (Joel Greenblatt) % | -366.9 | |||||
| ROCE % | -51.27 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.5 | |||||
| PB Ratio | 0.91 | |||||
| Price-to-Tangible-Book | 0.91 | |||||
| EV-to-Forward-EBIT | -0.14 | |||||
| EV-to-Revenue | 0.05 | |||||
| EV-to-Forward-Revenue | 0.05 | |||||
| EV-to-FCF | -0.01 | |||||
| Price-to-Net-Current-Asset-Value | 1.48 | |||||
| Price-to-Net-Cash | 1.83 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SYRS
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syros Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8.924 | ||
| EPS (TTM) ($) | -5.596 | ||
| Beta | 0.98 | ||
| Volatility % | 81.99 | ||
| 14-Day RSI | 22.42 | ||
| 14-Day ATR ($) | 0.19209 | ||
| 20-Day SMA ($) | 3.8985 | ||
| 12-1 Month Momentum % | -39.75 | ||
| 52-Week Range ($) | 2.42 - 6.95 | ||
| Shares Outstanding (Mil) | 20.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Syros Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Syros Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Syros Pharmaceuticals Inc Frequently Asked Questions
What is Syros Pharmaceuticals Inc(SYRS)'s stock price today?
The current price of SYRS is $3.21. The 52 week high of SYRS is $6.95 and 52 week low is $2.42.
When is next earnings date of Syros Pharmaceuticals Inc(SYRS)?
The next earnings date of Syros Pharmaceuticals Inc(SYRS) is 2023-11-14 Est..
Does Syros Pharmaceuticals Inc(SYRS) pay dividends? If so, how much?
Syros Pharmaceuticals Inc(SYRS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers